# ZenRise Clinical Research Pvt., Ltd – FDA Inspection, Jan 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/zenrise-clinical-research-pvt-ltd/38d1299c-ca1b-4336-8238-c8ffe2cbbe6b
Source feed: FDA_Inspections

> FDA inspection 1196700 of ZenRise Clinical Research Pvt., Ltd, January 20, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196700
- Company Name: ZenRise Clinical Research Pvt., Ltd
- Inspection Date: 2023-01-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1287248 - 2025-08-22
- FDA Inspection 1115999 - 2019-10-25

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)

Company: https://www.keypedia.com/companies/zenrise-clinical-research-pvt-ltd/700de278-23b2-4564-8812-238f821f636d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c